Sonoma Pharmaceuticals, Inc. SNOA
Sonoma Pharmaceuticals, Inc. statistics & valuation
Market cap$5.4M
P / S0.3×
P / B1.7×
Net margin-16.3%
Return on equity-102.6%
FCF margin-21.1%
Return on capital-27%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 38.0% | 38.2% | 37.3% | 33.7% | 31.6% | 35.2% | 45.3% | 46.8% | 43.9% | 44.2% |
| Operating margin | -12.6% | -26.0% | -36.9% | -34.4% | -46.6% | -18.5% | -41.2% | -59.3% | -85.2% | -101.2% |
| Net margin | -16.3% | -24.2% | -38.0% | -38.8% | -40.3% | -21.2% | -18.5% | -62.2% | -86.0% | 72.3% |
| FCF margin | -21.1% | -1.2% | -18.8% | -48.4% | -34.7% | -19.1% | -26.8% | -62.3% | -75.8% | -66.8% |
| Return on assets | -22.7% | -25.2% | -32.8% | -31.7% | -27.0% | -26.4% | -22.7% | -81.7% | -74.6% | 36.4% |
| Return on equity | -102.6% | -78.4% | -78.8% | -64.6% | -58.5% | -73.7% | -58.8% | -151.8% | -93.5% | 43.3% |
| Debt / equity | — | — | — | — | 0.00× | 0.24× | 0.00× | 0.04× | 0.02× | 0.01× |
| Current ratio | 2.50 | 3.09 | 3.37 | 3.71 | 2.82 | 3.18 | 2.60 | 3.48 | 4.98 | 6.89 |
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.